Download Sample
Add to CartGlobal Antibody Production Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
By Process;
Upstream processing - Bioreactors[Large-scale bioreactors and Single-use bioreactors], - Consumables[Media and Buffers and reagents] - Chromatography systems and Chromatography resins, Filtration - Filtration systems and Filtration consumables and accessories.By Product Type;
Polyclonal antibody and Monoclonal antibody - Murine monoclonal antibody, Chimeric monoclonal antibody and Humanized monoclonal antibody.By End Use;
Pharmaceutical and biotechnology companies, Research laboratories and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Antibody Production Market (USD Million), 2020 - 2030
In the year 2023, the Global Antibody Production Market was valued at USD 7,440.20 million. The size of this market is expected to increase to USD 12,668.78 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 7.9%.
Global Antibody Production Market Report Snapshot
| Parameters | Description |
|---|---|
| Market | Global Antibody Production Market |
| Study Period | 2020 - 2030 |
| Base Year (for Antibody Production Market Size Estimates) | 2023 |
| Drivers |
|
| Restraints |
|
| Opportunities |
|
Segment Analysis
This report extensively covers different segments of Global Antibody Production Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Antibody Production Segment Analysis
In this report, the Global Antibody Production Market has been segmented by Process, Product Type, End Use and Geography. The global antibody market is segmented by product type (monoclonal antibodies, polyclonal antibodies, antibody-drug complexes (adcs), end-user (hospitals, long-term care facilities, research institutes), and region. The study "Antibody production market " has been added to the researchandmarkets.Com portfolio. The increased acceptance of targeted immunotherapy, the increase in r&d spending of pharmaceutical and biotechnology companies, and the rising demand for therapeutic antibodies by the antibody industry are the primary drivers driving the growth of the antibody production market. The market report on monoclonal antibody therapy provides a thorough examination of the many aspects influencing the market. Opportunities, growth drivers, risks, major advances, and restrictions are among them.
Global Antibody Production Market, Segmentation by Process
The Global Antibody Production Market has been segmented by Process into Upstream processing, Downstream processing and Filtration.
Global Antibody Production Market, Segmentation by Product Type
The Global Antibody Production Market has been segmented by Product Type into Polyclonal antibody and Monoclonal antibody.
Global Antibody Production Market, Segmentation by End Use
The Global Antibody Production Market has been segmented by End Use into Pharmaceutical and biotechnology companies, Research laboratories and Others.
Global Antibody Production Market, Segmentation by Geography
In this report, the Global Antibody Production Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Antibody Production Market Share (%), by Geographical Region, 2023
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Antibody Production Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
Competitive Landscape Analysis
Key players in Global Antibody Production Market include:
- GE Healthcare
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- Merck KGaA
- Pall Corp.
- Eppendorf AG
- Cellab GmbH
- INTEGRA Biosciences AG
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Process
- Market Snapshot, By Product Type
- Market Snapshot, By End Use
- Market Snapshot, By Region
- Global Antibody Production Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increased demand for therapeutic antibodies
- Increasing investment in R&D
- Rising adoption of targeted therapy
- Restraints
- Intense competition among vendors
- Stringent government regulations
- Opportunities
- Drivers
- Regulatory Scenario
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market SegmentationCompetitive Landscape
- Global Antibody Production Market, By Process, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Upstream processing
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Bioreactors
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Large-scale bioreactors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Single-use bioreactors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Large-scale bioreactors
- Consumables
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Buffers and reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Media
- Bioreactors
- Downstream processing
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Chromatography systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Chromatography resins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Chromatography systems
- Filtration
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Filtration systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Filtration consumables and accessories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Filtration systems
- Upstream processing
- Global Antibody Production Market, By Product Type, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Polyclonal antibody
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Monoclonal antibody
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Murine monoclonal antibody
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Chimeric monoclonal antibody
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Humanized monoclonal antibody
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Murine monoclonal antibody
- Polyclonal antibody
- Global Antibody Production Market, By End Use, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Pharmaceutical and biotechnology companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Research laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pharmaceutical and biotechnology companies
- Global Antibody Production Market, By Geography, 2020 - 2030 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Antibody Production Market, By Process, 2020 - 2030 (USD Million)
- Competitive Landscape
- Company Profiles
- GE Healthcare
- Thermo Fisher Scientific, Inc.
- Sartorius AG
- Merck KGaA
- Pall Corp.
- Eppendorf AG
- Cellab GmbH
- INTEGRA Biosciences AG
- Company Profiles
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Anti-diabetic Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Anti-epileptic Drugs for Pediatrics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Antifungal Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Anti-infective Agents Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%